Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
EnGeneIC Pty Ltd a Sydneybased biotechnology company and leader in innovative cancer therapies has announced the successful dosing of the first patient in its openlabel multicentre Phase IIIa clinical trial at Mater Hospital
Intrepid Labs a biotechnology company transforming drug formulation development through the use of artificial intelligence AI and robotics emerged from stealth today to accelerate therapeutics development through effective formulations that improve c...
Genentech a member of the Roche Group announced today plans to invest more than million in a new square foot stateoftheart drug manufacturing facility in Holly Springs NC
Schreiner MediPharm presents the Digital Display Label a pioneering solution for digital marking of investigational drugs in clinical trials This innovative technology has the potential to replace conventional labels by electronic
Twist Bioscience Corporation a core midcap growth and value equity company in the life sciences segment of the health care sector and Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity
Zealand Pharma AS a biotechnology company focused on the discovery and development of innovative peptidebased medicines today announces that all closing conditions in the collaboration and license agreement with Roche announced on March
Colorcon a global leader of film coating systems specialty excipients controlled release formulations and controlled atmosphere packaging for the healthcare industry today announced an exclusive partnership with ASHA Cellulose
Amgen announced that the UKs Medicines and Healthcare products Regulatory Agency MHRA has granted marketing authorisation for TEPEZZA teprotumumab as the first therapy specifically licensed for the treatment of adult patients with moderatetosevere Th...
Positive highlevel results from the DESTINYBreast Phase III trial showed Enhertu trastuzumab deruxtecan followed by paclitaxel trastuzumab and pertuzumab THP demonstrated a statistically significant and clinically
Leica Microsystems a leading provider of microscopy and scientific instrumentation has launched the Visoria series of upright microscopes to help enhance the efficiency and comfort of routine microscopy work for pathologists
